Latest Strategy News

Abacus Group reported a solid FY25 with modest growth in funds from operations and stable distributions, underpinned by strong leasing activity and a diversified commercial portfolio. The Group also highlighted significant progress in sustainability and reaffirmed its FY26 guidance amid improving market conditions.

Emu NL announces the departure of CEO Adrian Griffin and the appointment of Non-Executive Director Peter Swiridiuk as interim CEO, signaling a leadership transition at the mining explorer.

Aspermont Limited's trading suspension has been lifted following a key announcement about new board appointments, signaling a fresh chapter for the media publisher.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Cann Group Limited has successfully raised an additional $2.5 million through a Share Purchase Plan and shortfall placement, complementing a prior $6.5 million institutional placement. These funds will primarily support debt repayment and strengthen the company’s financial position.

Growthpoint Properties Australia reported a robust FY25 with funds from operations exceeding guidance, expanded funds management assets, and achieved its Net Zero emissions target ahead of schedule. The company reaffirmed positive FY26 outlook amid leadership changes and ongoing sustainability commitments.

HeraMED has achieved a significant regulatory milestone with the Therapeutic Goods Administration upgrading its HeraBEAT fetal heart rate monitor to Class IIb, making it the only remote home-use device approved in Australia. This positions the company for a potentially lucrative expansion in the Australian maternity care market.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

Island Pharmaceuticals has engaged a top Washington DC government affairs firm to accelerate its US biodefence strategy, focusing on its antiviral drug Galidesivir amid promising FDA regulatory signals.

West Wits Mining has secured an initial US$12.5 million drawdown from its US$35 million Nebari facility, powering development at its Qala Shallows Gold Project in South Africa. The company reports key operational milestones, including first underground ore delivery and fleet expansion, targeting first gold pour by March 2026.

Emmerson Resources has updated the Mineral Resource Estimate for its White Devil gold deposit, reporting 616,200 ounces with a significant increase in Indicated resources. Feasibility studies are now underway, marking a key step towards development.

Saturn Metals has mobilised additional drilling rigs at its Apollo Hill Gold Project following promising assay results that extend the high-grade Iris Trend by 900 metres and highlight potential to grow the 2.24 million ounce resource.